These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 3456494)

  • 1. Aztreonam: disposition and pharmacokinetics in rats, dogs, and monkeys.
    Migdalof BH
    N J Med; 1986 Jan; Spec No():16-9. PubMed ID: 3456494
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative pharmacokinetics of carumonam and aztreonam in mice, rats, rabbits, dogs, and cynomolgus monkeys.
    Kita Y; Fugono T; Imada A
    Antimicrob Agents Chemother; 1986 Jan; 29(1):127-34. PubMed ID: 3729325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose and species dependent pharmacokinetics of a novel sigma receptor antagonist, DuP 734.
    Kapil RP; Lam GN
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):3-20. PubMed ID: 7620836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption, distribution and excretion of 3-(sulfamoyl[14C]methyl)-1,2-benziosoxazole (AD-810) in Rats, Dogs and Monkeys and of AD-810 in Men.
    Matsumoto K; Miyazaki H; Fujii T; Kagemoto A; Maeda T; Hashimoto M
    Arzneimittelforschung; 1983; 33(7):961-8. PubMed ID: 6138046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of aztreonam pharmacokinetics in humans based on data from animals.
    Swabb EA; Bonner DP
    J Pharmacokinet Biopharm; 1983 Jun; 11(3):215-23. PubMed ID: 6685766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of the new antidiabetic agent pioglitazone in rats, dogs, and monkeys.
    Maeshiba Y; Kiyota Y; Yamashita K; Yoshimura Y; Motohashi M; Tanayama S
    Arzneimittelforschung; 1997 Jan; 47(1):29-35. PubMed ID: 9037440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic properties of TDP4815 after single intravenous and oral administrations to rat, rabbit, monkey, dog and in vitro drug metabolism.
    Chen Y; Cheng D; Tio C; Kagan N; Eisennagel S; Dasgupta M; Tomczuk B; Bone R; Huebert N
    Biopharm Drug Dispos; 2008 Apr; 29(3):127-38. PubMed ID: 18186144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the pharmacokinetics of several polychlorinated biphenyls in mouse, rat, dog, and monkey by means of a physiological pharmacokinetic model.
    Lutz RJ; Dedrick RL; Tuey D; Sipes IG; Anderson MW; Matthews HB
    Drug Metab Dispos; 1984; 12(5):527-35. PubMed ID: 6149901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of the African green monkey as a preclinical pharmacokinetic model: intravenous pharmacokinetic parameters.
    Ward KW; Coon DJ; Magiera D; Bhadresa S; Nisbett E; Lawrence MS
    Drug Metab Dispos; 2008 Apr; 36(4):715-20. PubMed ID: 18227143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disposition and metabolism of [14C]brasofensine in rats, monkeys, and humans.
    Zhu M; Whigan DB; Chang SY; Dockens RC
    Drug Metab Dispos; 2008 Jan; 36(1):24-35. PubMed ID: 17908924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of the antipsychotic agent CI-1007 in rats, monkeys, dogs, and human cytochrome P450 2D6 extensive metabolizers. Species comparison and allometric scaling.
    Feng MR; Loo J; Wright J
    Drug Metab Dispos; 1998 Oct; 26(10):982-8. PubMed ID: 9763403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics.
    Yang Z; Zadjura L; D'Arienzo C; Marino A; Santone K; Klunk L; Greene D; Lin PF; Colonno R; Wang T; Meanwell N; Hansel S
    Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and disposition of novel des-fluoro quinolone garenoxacin in experimental animals and an interspecies scaling of pharmacokinetic parameters.
    Hayakawa H; Fukushima Y; Kato H; Fukumoto H; Kadota T; Yamamoto H; Kuroiwa H; Nishigaki J; Tsuji A
    Drug Metab Dispos; 2003 Nov; 31(11):1409-18. PubMed ID: 14570774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and tissue penetration of a new carbapenem, doripenem, intravenously administered to laboratory animals.
    Hori T; Nakano M; Kimura Y; Murakami K
    In Vivo; 2006; 20(1):91-6. PubMed ID: 16433034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 3rd communication: plasma concentrations of the unchanged drug and its deethylated metabolite in rats, dogs and monkeys.
    Nakamura A; Hirota T; Sugihara K; Morino A
    Arzneimittelforschung; 1997 Feb; 47(2):169-74. PubMed ID: 9079236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition and metabolism of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine in rats, dogs, and monkeys.
    Hucker HB; Hutt JE; White SD; Arison BH; Zacchei AG
    Drug Metab Dispos; 1983; 11(1):54-8. PubMed ID: 6132797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.